894493-95-9

Basic information

• Product Name: (1S,2S)-(+)-N,N-Dimethylcyclohexane-1,2-diamine
• Synonyms: (1S,2S)-(+)-N,N-Dimethyl diaminocyclohexane;(1S,2S)-N1,N1-Dimethylcyclohexane-1,2-diamine;(1S,2S)-(+)-N,N-Dimethylcyclohexane-1,2-diamine;(1S,2S)-N,N-Dimethyl-1,2-cyclohexanediamine;1R,2R-(-)-OR1S,2S-(+)-N,N-DIAMINOCYCLOHEXANE;N,N'-Dimethyl-1S,2S-Diaminocyclohexane;(1S,2S)-1-N,1-N-diMethylcyclohexane-1,2-diaMine;1S,2S-(+)-N,N-diaminocyclohexane
• CAS NO: 894493-95-9
• Molecular Formula: C₈H₁₈N₂
• Molecular Weight: 142.24
• Mol File: 894493-95-9.mol

Chemical Properties

• Boiling Point: 180 °C
• Flash Point: 62 °C
• Appearance: /
• Density: 0.92
• Refractive Index: 1.49
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 10.52±0.70(Predicted)
• CAS DataBase Reference: (1S,2S)-(+)-N,N-Dimethylcyclohexane-1,2-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,2S)-(+)-N,N-Dimethylcyclohexane-1,2-diamine(894493-95-9)
• EPA Substance Registry System: (1S,2S)-(+)-N,N-Dimethylcyclohexane-1,2-diamine(894493-95-9)

Safety Data

• Statements: 22-34
• Safety Statements: 26-36/37/39-45
• RIDADR: 2735
• HazardClass: 8
• PackingGroup: Ⅲ
• Hazardous Substances Data: 894493-95-9(Hazardous Substances Data)

Usage

Chemical Properties

Colorless liquid

InChI:InChI=1/C8H18N2/c1-10(2)8-6-4-3-5-7(8)9/h7-8H,3-6,9H2,1-2H3/t7-,8-/m0/s1

Upstream product

• 620597-07-1 N,N-dimethyl-N'-benzyl-1,2-cyclohexanediamine 
• 124-63-0 methanesulfonyl chloride 
• 100-46-9 benzylamine 
• 286-18-0 7-azabicyclo[4.1.0]heptane 
• 931-15-7 (1S,2S)-trans-2-aminocyclohexanol 

Downstream Products

• 620960-26-1 1-[3,5-bis(trifluoromethyl)phenyl]-3-[(1S,2S)-2-(dimethylamino)cyclohexyl]thiourea 
• 1165796-67-7 C₁₃H₂₇N₃O₂S 
• 1165796-68-8 C₂₄H₄₁N₃O₂S 
• 1373404-83-1 N-((1S,2S)-2-(3-((1S,2S)-2-(dimethylamino)cyclohexyl)thioureido)cyclohexyl)-1,1,1-trifluoromethanesulfonamide 
• 1384718-12-0 1-((1R,2R)-2-aminocyclohexyl)-3-((1S,2S)-2-(dimethyl amino)cyclohexyl)thiourea 

Relevant articles and documents

Preparation of C 2-Symmetric Biaryl Bisiminium Salts and Their Use as Organocatalysts for Asymmetric Epoxidation

Two C 2-symmetric bisiminium salt species containing biphenylazepinium units and derived from two chiral diamines were prepared and tested as organocatalysts for asymmetric epoxidation.

Stereoselective reaction of 2-carboxythioesters-1,3-dithiane with nitroalkenes: An organocatalytic strategy for the asymmetric addition of a glyoxylate anion equivalent

An efficient organocatalytic methodology has been developed to perform the stereoselective addition of 2-carboxythioesters-1,3-dithiane to nitroalkenes. Under mild reaction conditions γ-nitro-β-aryl-α-keto esters with up to 92% ee were obtained, realizing a formal catalytic stereoselective conjugate addition of the glyoxylate anion synthon. The reaction products are versatile starting materials for further synthetic transformations; for example, the simultaneous reduction of the nitro group and removal of the dithiane ring was accomplished, allowing the preparation of a GABAB receptor agonist baclofen.

Asymmetric isomerization of ω-hydroxy-α,β-unsaturated thioesters into β-mercaptolactones by a bifunctional aminothiourea catalyst

We present a novel methodology for the asymmetric synthesis of β-mercaptolactones via isomerization of ω-hydroxy-α,β- unsaturated thioesters by means of a bifunctional aminothiourea catalyst. The catalyst interacts with the substrate through the cooperati

Asymmetric Michael addition of arylthiols to α,β-unsaturated carbonyl compounds catalyzed by bifunctional organocatalysts

Bifunctional chiral organocatalysts comprising thiourea and tertiary amine groups were synthesized. They act as efficient catalysts for asymmetric Michael addition of arylthiols to α,β-unsaturated carbonyl compounds. Enantioselectivity up to 85% has been achieved. Asymmetric α-protonation reaction (up to 60% ee) can be obtained in the presence of the bifunctional catalyst.

Analgesic N-[2-(furyl-methylamino and 2-thienylmethylamino)cycloaliphatic]be

Cis - and trans-N-(2-aminocycycloaliphatic)benzamide compounds of the formula STR1 e.g., N-methyl-N-[2-[(2-furylmethyl)methylamino]-cyclohexyl]-3,4-dichlorobenzamide, and their pharmaceutically acceptable salts, have been found to have potent analgesic activity, and compositions containing these compounds useful in pharmaceutical dosage unit form for alleviating pain in warm-blooded animals, as well as methods for alleviating pain in animals with these compositions. Processes for preparing the compounds are also disclosed.

Analgesic N-{2-[N'-(2-furylmethyl and 2-thienyl-methyl)-N'-alkylamino]cycloaliphatic}cyanobenzamides

Cis- and trans-N-(2-aminocycloaliphatic)benzamide compounds of the formula STR1 e.g., N-methyl-N-[2-(N-pyrrolidinyl)cyclohexyl]-3,4-dichlorobenzamide, and their pharmaceutically acceptable salts, have been found to have potent analgesic activity, and compositions containing these compounds useful in pharmaceutical dosage unit form for alleviating pain in warm blooded animals, as well as methods for alleviating pain in animals with these compositions. Processes for preparing the compounds are also disclosed.

Analgesic N-(2-aminocycloaliphatic)benzamides

Cis- and trans-N-(2-aminocycloaliphatic)benzamide compounds of the formula STR1 E.G., N-methyl-N[2-(N-pyrrolidinyl)cyclohexyl[3,4-dichlorobenzamide, and their pharmaceutically acceptable salts, have been found to have potent analgesic activity, and compositions containing these compounds useful in pharmaceutical dosage unit form for alleviating pain in warm blooded animals, as well as methods for alleviating pain in animals with these compositions. Processes for preparing the compounds are also disclosed.